Catalyst Wire Dossier Catalyst Wire Dossier

DTPa-HBV-IPV/Hib vaccine (pentavalent)

Diphtheria and tetanus toxoids, acellular pertussis, Hepatitis B, Haemophilus influenzae type b conjugate vaccine, inactivated poliovirus · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DTPa-HBV-IPV/Hib vaccine (pentavalent), covering 2016-09-28 to 2016-09-28. Get the full timeline:

Most recent: Clinical Trial Update: Immunogenicity & Safety of GSK's Combined DTPa-HBV-IPV/Hib Vaccine in Indian Infants at 2 Diff Vaccination Schedules [Phase 3]

See pricing